Express News | Cytokinetics to Announce Third Quarter Results on November 6, 2024

Breakings04:00

B.Riley Financial Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $92

Futu NewsOct 23 20:31 · Ratings

Possible Bearish Signals With Cytokinetics Insiders Disposing Stock

Simply Wall StOct 22 21:28

Oppenheimer Buy-rated Ideas: BSX, MDT, and One Hold: CYTK

Seeking AlphaOct 18 23:21

A Quick Look at Today's Ratings for Cytokinetics(CYTK.US), With a Forecast Between $72 to $120

Futu NewsOct 18 21:00 · Ratings

Cantor Fitzgerald Reiterates Overweight on Cytokinetics

BenzingaOct 18 20:00